In response: Surrogate measures should be abandonded

By Channer Kevin S  

Clinical Medicine, Vol. 5, Iss. 3, 2005-05 ,pp. : 287-288

Royal College Of Physicians

Access to resources Recommend Favorite

Lipid-Lowering Therapy for the Primary Prevention of Cardiovascular Disease in the Elderly: Opportunities and Challenges

By Robinson Jennifer G.  

Drugs & Aging, Vol. 26, Iss. 11, 2009-11 ,pp. : 917-931

Adis International

Access to resources Recommend Favorite

Pharmacogenomics in cardiovascular disease: the role of single nucleotide polymorphisms in improving drug therapy

By Mango Ruggiero   Vecchione Lucia   Raso Barbara   Borgiani Paola   Brunetti Ercole   Mehta Jawahar L   Lauro Renato   Romeo Francesco   Novelli Giuseppe  

Expert Opinion on Pharmacotherapy, Vol. 6, Iss. 15, 2005-12 ,pp. : 2565-2576

Informa Healthcare

Access to resources Recommend Favorite

Pharmaceutical thrombosis prevention in cardiovascular disease

By Eriksson Mats   Christensen Kjeld   Lindahl Tomas L   Larsson Anders  

Expert Opinion on Investigational Drugs, Vol. 11, Iss. 4, 2002-04 ,pp. : 553-563

Informa Healthcare

Access to resources Recommend Favorite

Lipid Management for the Prevention of Cardiovascular Disease

By  

Current Pharmaceutical Design, Vol. 17, Iss. 9, 2011-03 ,pp. : 852-860

Bentham Science Publishers

Access to resources Recommend Favorite